Michael Austin profile picture

Contact Information

Michael Austin, MD, FRCPC
613 737-7228
maustin@toh.ca

Research Administrative Assistant:
Jane Marchand
Tel: 613 737-7228
Ext. 77911
jamarchand@rppeo.ca

Funding



May 2023
LIFETIME FUNDING
Total peer-reviewed funding received... $2,001,088.74
As Principal Investigator………………...$1,901,133.54



















Peer-reviewed research funding

Support
Period Title Organization Role Total Amount
2023-2025 Occupational Exposure Study and MayDay PI: M. Austin $351,835.00
RCT Paramedics Analgesia
Methoxyflurane Study
2022-2023 Paramedics Providing Palliative Care CPAC/HEC PI: M. Austin    $252,545.34
2019-2022 Paramedics Providing Palliative Care  CPAC/CFHI PI: M. Austin  $853,351.00
2019-2020 Paramedic Analgesia in adults using  DEM, TOH PI: M. Austin  $9,901.00
INhaled (PAIN) Methoxyflurane Study
2018-2021 RCT feasibility study to evaluate  DOD USA PI: M. Austin  $305,974.40
the effects of controlled (automated)
administration of oxygen (FreeO2) in ambulances for COPD and Trauma
RESEARCH GRANTS
MayDay ($351,835.00) (2023) (Principle Investigator). Prehospital Inhaled Methoxyflurane Non-Clinical Occupational Exposure Study & Prehospital Analgesia in Adults using Inhaled (PAIN) Methoxyflurane Study.

Health Excellence Canada and Canadian Partnership Against Cancer ($252,545.00) (Co-Principle Investigator) Implementation Project. Paramedics Providing Palliative Care in home

Department of Emergency Medicine (DEM) Ottawa ($9,901.00) (2019), (Principle Investigator) Prehospital Analgesia in Adults using Inhaled Methoxyflurane: A Feasibility Study

Canadian Partnership against Cancer and Canadian Foundation for Health Improvement ($853,351.00) (Co-Principle Investigator) Implementation Project. Paramedics Providing Palliative Care in Home

Cincinnati University Grant/Department of Defense USA ($105,974.40) (2018), (Principle Investigator of study with subset of budget) Randomised, Controlled, prospective feasibility study to evaluate the effects of controlled (automated) administration of oxygen (FreeO2) in ambulances for COPD and trauma patients.

Department of Emergency Medicine (DEM) Ottawa ($4,553.00) (Co-investigator) (2013)
Assessment of characteristics, management and short-term adverse events of transported and non-transported patients with hypoglycemia treated by paramedics.

Academic Health Science Centre (AHSC) AFP Innovation Fund ($99,955.20) (2012 ongoing) (Co-investigator) A Prospective Evaluation of the Safety and Effectiveness of a Provincial Pre-hospital Trauma Bypass Guideline for Adult Major Trauma Patients in Eastern Ontario

Respironics ($6,000) (2009) (Principle Investigator) A randomized clinical trial of continuous positive airway pressure (CPAP) in the treatment of acute cardiogenic pulmonary oedema (APO) patients in the pre-hospital setting. Austin MA 2009

Australian College Ambulance Professionals (ACAP) ($1000) (2006) (Principle Investigator) A randomised trial comparing “controlled” oxygen therapy with “high-flow” oxygen therapy in the pre-hospital setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Wood-Baker R, Austin MA 2005-2007

Flaem Nuova ($10,000) (2006) (Principle Investigator) A randomised trial comparing “controlled” oxygen therapy with “high-flow” oxygen therapy in the pre-hospital setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Wood-Baker R, Austin MA 2005-2007